The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer, of which approximate 4% had BRAF activation, with an option for targeted therapy. BRAF activation comprises of V600 and non-V600 mutations, fusion, rearrangement, in-frame deletions, insertions, and co-mutations. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Longyao, Zheng, Linpeng, Yang, Qiao, Sun, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326470/
https://www.ncbi.nlm.nih.gov/pubmed/35912223
http://dx.doi.org/10.3389/fonc.2022.882940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326470/
https://www.ncbi.nlm.nih.gov/pubmed/35912223
http://dx.doi.org/10.3389/fonc.2022.882940

Ejemplares similares